Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | Brain Magnetic Resonance Imaging (MRI) | - | - | - | - | [1] 17 17 |
2 | Dynamic Contrast-Enhanced Magnetic Resonance Imaging | - | - | - | - | [1] 13 13 |
3 | Functional Magnetic Resonance Imaging | - | - | - | - | [1] 6 6 |
4 | Locally approved intravenous contrast medium for contrast enhanced magnetic resonance imaging (MRI) | - | - | - | - | [1] 13 13 |
5 | Magnetic Resonance Imaging | - | - | - | - | [7] 6 6, 13, 19, 22, 34, 205, 299 |
6 | Magnetic Resonance Imaging (MRI) | - | - | - | - | [1] 46 46 |
7 | Magnetic resonance imaging (MRI) with gadolinium enhancement | [1] Gadolinium Gadolinium | - | - | - | [1] 58 58 |
8 | Magnetic resonance imaging (MRI) without gadolinium enhancement | [1] Gadolinium Gadolinium | - | - | - | [1] 58 58 |
9 | Magnetic resonance imaging of the brain | - | - | - | - | [1] 78 78 |
10 | Other: Brain MRI (magnetic resonance imaging) | - | - | - | - | [1] 17 17 |
11 | Other: Magnetic Resonance Imaging (MRI) | - | - | - | - | [1] 113 113 |